1. Home
  2. NU vs SIGA Comparison

NU vs SIGA Comparison

Compare NU & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NU
  • SIGA
  • Stock Information
  • Founded
  • NU 2013
  • SIGA 1995
  • Country
  • NU Brazil
  • SIGA United States
  • Employees
  • NU N/A
  • SIGA N/A
  • Industry
  • NU Finance: Consumer Services
  • SIGA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NU Finance
  • SIGA Health Care
  • Exchange
  • NU Nasdaq
  • SIGA Nasdaq
  • Market Cap
  • NU 57.9B
  • SIGA 422.9M
  • IPO Year
  • NU 2021
  • SIGA 1997
  • Fundamental
  • Price
  • NU $13.58
  • SIGA $6.69
  • Analyst Decision
  • NU Buy
  • SIGA
  • Analyst Count
  • NU 8
  • SIGA 0
  • Target Price
  • NU $15.50
  • SIGA N/A
  • AVG Volume (30 Days)
  • NU 75.6M
  • SIGA 405.0K
  • Earning Date
  • NU 08-14-2025
  • SIGA 07-31-2025
  • Dividend Yield
  • NU N/A
  • SIGA 8.97%
  • EPS Growth
  • NU 69.16
  • SIGA N/A
  • EPS
  • NU 0.44
  • SIGA 0.67
  • Revenue
  • NU $5,645,577,000.00
  • SIGA $120,330,310.00
  • Revenue This Year
  • NU $166.94
  • SIGA N/A
  • Revenue Next Year
  • NU $26.23
  • SIGA $95.31
  • P/E Ratio
  • NU $30.92
  • SIGA $9.97
  • Revenue Growth
  • NU 32.91
  • SIGA N/A
  • 52 Week Low
  • NU $9.01
  • SIGA $4.95
  • 52 Week High
  • NU $16.15
  • SIGA $12.83
  • Technical
  • Relative Strength Index (RSI)
  • NU 63.18
  • SIGA 61.77
  • Support Level
  • NU $13.34
  • SIGA $6.34
  • Resistance Level
  • NU $13.99
  • SIGA $6.81
  • Average True Range (ATR)
  • NU 0.47
  • SIGA 0.26
  • MACD
  • NU 0.12
  • SIGA 0.02
  • Stochastic Oscillator
  • NU 83.76
  • SIGA 82.50

About NU Nu Holdings Ltd.

Nu Holdings Ltd provides digital banking services. It offers several financial services such as Credit cards, Personal accounts, Investments, Personal Loans, Insurance, Mobile payments, Business Accounts, and Rewards. The company earns the majority of its revenue in Brazil.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Share on Social Networks: